Clean Blood, Religion, and Moral Triage in Tuberculosis Vaccine Trials

被引:9
|
作者
Dixon, Justin [1 ,2 ]
Tameris, Michele [3 ]
机构
[1] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London, England
[2] Univ Durham, Dept Anthropol, Durham, England
[3] Univ Cape Town, Inst Infect Dis & Mol Med, Dept Pathol, Cape Town, South Africa
基金
英国经济与社会研究理事会;
关键词
South Africa; bioethics; clinical trials; morality; religion; tuberculosis; MEDICAL-RESEARCH; PERSPECTIVES; REFLECTIONS; EXPERIENCES; COMMUNITY; SCIENCE; ETHICS; NURSES; TRUTH;
D O I
10.1080/01459740.2018.1463528
中图分类号
Q98 [人类学];
学科分类号
030303 ;
摘要
During ethnographic research at a tuberculosis vaccine trial site in South Africa, trial participants often evoked the idiom of "clean blood." In this article, we illustrate how the trials enacted a form of moral triage in which "objective" bioscientific knowledge and moral subjectivity were coproduced. Participation created possibilities to demonstrate healthiness, respectability, and godliness in a context where positive self-imaginings were hard won, but could also lead to dejection and shame. We suggest that struggles to be recognized as virtuous are often overlooked in anthropological critiques of clinical trials and bioethics, but are important for understanding how trials meld with local moral worlds.
引用
收藏
页码:708 / 721
页数:14
相关论文
共 50 条
  • [12] A comparison of IFNγ detection methods used in tuberculosis vaccine trials
    Beveridge, Natalie E. R.
    Fletcher, Helen A.
    Hughes, Jane
    Pathan, Ansar A.
    Scriba, Thomas J.
    Minassian, Angela
    Sander, Clare R.
    Whelan, Kathryn T.
    Dockrell, Hazel M.
    Hill, Adrian V. S.
    Hanekom, Willem A.
    McShane, Helen
    TUBERCULOSIS, 2008, 88 (06) : 631 - 640
  • [13] An Aspiration to Radically Shorten Phase 3 Tuberculosis Vaccine Trials
    Hill, Philip C.
    Cobelens, Frank
    Martinez, Leonardo
    Behr, Marcel A.
    Churchyard, Gavin
    Evans, Tom
    Fiore-Gartland, Andrew J.
    Garcia-Basteiro, Alberto L.
    Hanekom, Willem
    Rangaka, Molebogeng X.
    Vekemans, Johan
    White, Richard G.
    JOURNAL OF INFECTIOUS DISEASES, 2023, 228 (09): : 1150 - 1153
  • [15] Consensus Statement on Diagnostic End Points for Infant Tuberculosis Vaccine Trials
    Hatherill, Mark
    Verver, Suzanne
    Mahomed, Hassan
    CLINICAL INFECTIOUS DISEASES, 2012, 54 (04) : 493 - 501
  • [16] Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations
    Hanekom, Willem A.
    Dockrell, Hazel M.
    Ottenhoff, Tom H. M.
    Doherty, T. Mark
    Fletcher, Helen
    McShane, Helen
    Weichold, Frank F.
    Hoft, Dan F.
    Parida, Shreemanta K.
    Fruth, Uli J.
    PLOS MEDICINE, 2008, 5 (07) : 1033 - 1036
  • [17] Designing tuberculosis vaccine efficacy trials - lessons from recent studies
    Ginsberg, Ann M.
    EXPERT REVIEW OF VACCINES, 2019, 18 (05) : 423 - 432
  • [18] Phenotypic variability in childhood TB: Implications for diagnostic endpoints in tuberculosis vaccine trials
    Mulenga, Humphrey
    Moyo, Sizulu
    Workman, Lesley
    Hawkridge, Tony
    Verver, Suzanne
    Tameris, Michele
    Geldenhuys, Hennie
    Hanekom, Willem
    Mahomed, Hassan
    Hussey, Gregory
    Hatherill, Mark
    VACCINE, 2011, 29 (26) : 4316 - 4321
  • [19] A Review of Adherence and Predictors of Adherence to the CONSORT Statement in the Reporting of Tuberculosis Vaccine Trials
    Ngah, Veranyuy D.
    Mazingisa, Akhona V.
    Zunza, Moleen
    Wiysonge, Charles S.
    VACCINES, 2020, 8 (04) : 1 - 13
  • [20] Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
    Mangtani, Punam
    Abubakar, Ibrahim
    Ariti, Cono
    Beynon, Rebecca
    Pimpin, Laura
    Fine, Paul E. M.
    Rodrigues, Laura C.
    Smith, Peter G.
    Lipman, Marc
    Whiting, Penny F.
    Sterne, Jonathan A.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (04) : 470 - 480